In vitro, OGT KO inhibits O-GlcNAcylation at the YAP1 Ser109, thereby inhibiting cell-colony formation in pancreatic cancer; in vivo, OGT knockdown downregulates tumor growth (Peng et al., 2017). This evidence concerns the gene OGT and pancreatic neoplasm.